Home / Forums / TopicsDrugs could impact COVID-19 infection via other MoA Drugs could impact COVID-19 infection via other MoA Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) 1 2 Modelling in Herbal formulations Started by Gberindyer Fidelis Andover in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) 2 3 In vitro+PK: Lopinavir/ritonavir-importance of loading Started by Gberindyer Fidelis Andover in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) 1 1 Webinar Q: For drugs that partition intracellularly… Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) 3 3 Webinar Q: do you have values from the site of action (i.e. lung) Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14) 1 1 mRNA-1273 Started by J WC in: Vaccines for COVID-19 2 2 Therapeutic levels for Hydroxychloroquine Started by KajsaHamberg in: Therapeutics for COVID-19 2 2 Clinical investigation timelines and approval process Started by J WC in: Regulatory Considerations 2 2 Viral dose Started by J WC in: General Questions 1 1 Adjuvant therapies Started by J WC in: General Questions 1 1 Azithromycin and Hydroxychloroquine Started by MT24b in: Therapeutics for COVID-19 2 3 Children in COVID-19 clinical studies Started by J WC in: General Questions 1 1 SARS & MERS compared with COVID-19 Started by J WC in: General Questions 1 1 COVID-19 incidence in Africa Started by J WC in: General Questions 1 1 Heparin Started by J WC in: Therapeutics for COVID-19 1 1← 1 2 3 4 →